Latest filing published 17 Jun 2026 for BeOne Medicines Ltd..
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Since each purchase
- +41.5%Entry US$270.15 · Close 22 Oct 2026 US$382.27
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Sawyers Charles Lazelle: trading record in brief
All filings by Sawyers Charles Lazelle on record concern BeOne Medicines Ltd. In total, 2 filings cover trades dated 11 June 2026.
The open-market record is one-sided, with 1 purchase and not one sale. The totals exclude 1 filing filed without an amount. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant.
The newest entry dates from 17 June 2026: an open-market purchase, in BeOne Medicines Ltd. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Sawyers Charles Lazelle
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 18,980 sharesShareXHKGHKEX:DA20260616E00536Canonical exit: 9 Sept 2026 (T+90)
- 25,302 sharesShareXHKGHKEX:DA20260616E00535
2 of 2 declarations
